���ϸ�����

News from ���ϸ����� Langone Health

Common Chemicals In Plastic Linked To Over 350,000 Deaths From Heart Disease. (Washington Post)

The (4/29) A study conducted by ���ϸ����� Grossman School of Medicine published Tuesday in eBioMedicine, found that phthalates contributed to more than 350,000 deaths from cardiovascular disease globally in 2018, with about 75% of those deaths occurring in Asia, the Middle East, and the Pacific, with Leonardo Trasande, MD, MPP, the Jim G. Hendrick, M.D. Professor of Pediatrics, Department of Pediatrics, and professor, Department of Population Health and co-author of the paper, saying, “We think of plastics as an issue in high-income countries,” but” what we’re seeing in the pattern geographically is disturbing.”

Chemical In Plastics Linked To 350K Heart Disease Deaths: Research. (4/29) Lead author Sara Hyman, an associate research scientist at ���ϸ����� Grossman School of Medicine, said, “Our findings add to the vast body of evidence that these chemicals present a tremendous danger to human health,” noting that the study, which builds on the team’s 2021 research connecting these chemicals to over 50,000 premature deaths annually in older Americans, is likely the first of its kind globally. Leonardo Trasande, MD, MPP, the Jim G. Hendrick, M.D. Professor of Pediatrics, Department of Pediatrics, and professor, Department of Population Health, added, “Our results underscore the urgent need for global regulations to reduce exposure to these toxins, especially in areas most affected by rapid industrialization and plastic consumption.”

Also reporting are (4/29) the (4/29), (4/29), (4/29), (4/29), (4/29), (4/29), (4/29), (4/29), (4/29), (4/29), (4/29), (4/29) and (4/29).

How Ozempic Is Shaping Weddings. (New York Times)

The (4/29) Discussing the impacts of side effects from the use of CLP-1 drugs to lose weight before weddings, Melanie R. Jay, MD, professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, and Department of Population Health, said, “I wouldn’t start taking these medicines a few weeks before an event like a wedding.”

Why Life Expectancy Varies Widely Across The US Especially For Women, New Study Reveals. (NBC News)

(4/29) A new study from researchers at the Yale School of Public Health found significant geographic disparities in life expectancy across the U.S., with Southern states, especially for women, showing minimal improvement over the past century, while states like New York and California have seen substantial gains, with Marc N. Gourevitch, MD, MPH, the Muriel G. and George W. Singer Professor of Population Health, chair, Department of Population Health, professor, Departments of Medicine and Psychiatry, who was not involved in the study, saying, “Focusing on policies that help people better meet their everyday needs promises to go a long way in improving life expectancy and, with it, giving more people a chance at getting to watch their grandchildren grow.” 

Best Dermatologist-Approved Sunburn Treatments. (NBC News)

(4/29) Discussing sunburn treatments, Mary L. Stevenson, MD, associate professor, the Ronald O. Perelman Department of Dermatology, said that a “prescription-strength silver sulfadiazine topical cream is commonly given to patients with more severe burns.”

100 Academic Medical Centers To Know. (Becker's Hospital Review)

(4/29) ���ϸ����� Langone Health, ranks No. 1 in quality care nationally (Vizient) and among the top 20 hospitals in 13 specialties (U.S. News & World Report 2024-25); the article notes its role in medical milestones such as face and double-hand transplants and genetically modified organ transplants.

Confronting Prostate Cancer Misinformation In The Digital Age. (Targeted Oncology)

(4/29) Discussing online myths and misinformation about prostate cancer, Stacy Loeb, MD, professor, Departments of Urology and Population Health, Perlmutter Cancer Center, said, “Prostate cancer misinformation is widespread across online platforms and spans many different aspects of the disease. This can lead to real consequences, such as unrealistic expectations, delayed or missed screening, or even financial harm from spending on unproven treatments.”

CAD And Inflammation: What’s The Connection? (Medscape)

(4/29)* A recent trial showing colchicine’s failure to reduce cardiovascular events following myocardial infarction has led cardiologists to reassess the role of inflammation in coronary artery disease (CAD) treatment, with Kathryn J. Moore, PhD, the Jean and David Blechman Professor of Cardiology, Department of Medicine, the Leon H. Division of Cardiology, and professor, Department of Cell Biology, saying, “Atherosclerosis is caused by vascular inflammation due to cholesterol deposition that occurs with hyperlipidemia,” noting the “immune system recognizes the accumulated lipids as foreign, setting off an inflammatory response in the artery wall, which if not resolved, leads to the formation of plaque.”

Experts Are Telling Us How Your Period Can Seriously Impact This One Body Part. (BuzzFeed)

(4/29) Hormonal fluctuations during the menstrual cycle, specifically changes in estrogen and progesterone levels, can make gums more sensitive and prone to inflammation, increasing the risk of gingivitis, with Margaret Nachtigall, MD, clinical associate professor, Department of Obstetrics and Gynecology, saying, “As estrogen levels increase, there is more blood flow to the gums, and progesterone can also increase inflammation, sometimes making the gums more reactive.”

Cancer Trial Holds Promising Results. (KCBS-TV Los Angeles)

(4/29 Jonathan D. LaPook, MD, the Mebane Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health highlights an immunotherapy trial at Memorial Sloan Kettering Cancer Center has shown an 80% success rate in treating patients with solid tumors, with one patient’s cancer vanishing after just six months, eliminating the need for chemotherapy, radiation, or surgery,